Unrestricted funding for the in-person Scottsdale RAND Appropriateness Panel meeting was generously provided by Warner-Chilcott, Abbott, and Shire. Unrestricted funding for the BRIDGe group is provided by Abbott, Salix, Shire, UCB, and Warner-Chilcott
Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groups†
Version of Record online: 15 FEB 2012
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 18, Issue 12, pages 2294–2300, December 2012
How to Cite
Cheifetz, A.S., Melmed, G.Y., Spiegel, B., Talley, J., Devlin, S.M., Raffals, L., Irving, P.M., Jones, J., Kaplan, G.G., Kozuch, P., Sparrow, M., Velayos, F., Baidoo, L., Bressler, B. and Siegel, C.A. (2012), Setting priorities for comparative effectiveness research in inflammatory bowel disease: Results of an international provider survey, expert rand panel, and patient focus groups. Inflamm Bowel Dis, 18: 2294–2300. doi: 10.1002/ibd.22920
- Issue online: 15 NOV 2012
- Version of Record online: 15 FEB 2012
- Manuscript Accepted: 24 JAN 2012
- Manuscript Received: 23 DEC 2011
- 1Initial national priorities for comparative effectiveness research. In: Medicine Io, ed. Washington DC: National Academies Press; 2009., , , , , eds.
- 4Protocol Analysis: Verbal Reports as Data (Revised Edition). Cambridge, MA: MIT Press, 1993..
- 6The RAND/UCLA Appropriateness Method. Clinical Practice Guideline Development: Methodology Perspectives. Rockville, MD: AHCR; 1994..